Lutein prevents the effect of high glucose levels on immune system cells in vivo and in vitro

Journal of Physiology and Biochemistry

Volumn 64, Issue 2, 2008, Pages 149-157

  Muriach, M ^a   Bosch Morell, F ^a   Arnal, E ^a   Alexander, G ^b   Blomhoff, R ^b   Romero, F J ^a  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antioxidants; Hyperglycemia; Infection; Lipid peroxidation; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MALONALDEHYDE; XANTHOPHYLL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; RAT;

RATTUS;

EID: 56349160605     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03168243     Document Type: Article

References (33)

1. Barzilay, J.I., Abraham, L., Heckbert, S.R., Cushman, M., Kuller, L.H., Resnick, H.E. and Tracy, R.P. (2001): The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 50, 2384-2389.
2. Baynes, J.W. and Thorpe, S.R. (1999): Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes, 48, 1-9.
3. Brownlee, M., Cerami, A. and Vlassara, H. (1988): Advanced glycosylation end products in tissue and the biochemical basis of diabetes complications. N Engl J Med, 318, 1315-1321.
4. Bunting, K., Rao, S., Hardy, K., Waltring, D., Denyer, G.S., Wang, J., Gerondakis, S. and Shannon, M.F. (2007): Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappaB transcrition factor c-Rel. J Immunol, 178, 7097-7109.
5. Carlsen, H., Moskaug, J.O., Fromm, S.H. and Blomhoff, R. (2002): In vivo imaging of NF-kappaB activity. J Immunol, 168, 1441-1446.
6. Chew, B.P., Brown, C.M., Park, J.S. and Mixter, P.F. (2003): Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res, 23, 3333-3339.
7. Dandona, P., Aljada, A. and Mohanty, P. (2002): The anti-inflammatory and potential antiatherogenic effect of insulin: a new paradigm. Diabetologia, 45, 924-930.
8. Guha, M., Bai, W., Nadler, J.L. and Natarajan, R. (2000): Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem, 275, 17728-17739.
9. Halliwell, B. (2000): Oxidative stress markers in human disease: application to diabetes and to evaluation of the effects of antioxidants. In "Antioxidants in Diabetes Management", (Packer L, Rösen P, Tritschler HJ, King GL & Azzi A, eds.), Marcel Dekker, New York, pp. 33-52.
10. Hofmann, M.A., Schiekofer, S., Kanitz, M., Klevesath, M.S., Joswig, M., Lee, W., Morcos, M., Tritschler, H., Ziegler, D., Wahl, P., Bierhaus, A. and Nawroth, P.P. (1998): Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care, 21, 1310-1316.
11. Hotta, N. (1995): New approaches for treatment of diabetes: aldose reductase inhibitors. Biomed Pharmacother, 49, 232-243.
12. Ido, Y., Kilo, C. and Williamson, J.R. (1997): Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia, 40 (suppl. 2), S115-S117.
13. Ishii, H., Daisuke, K. and King, G.L. (1998): Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med, 76, 21-31.
14. Joshi, N., Caputo, G.M., Weitekamp, M.R. and Karchmer, A.W. (1999): Infections in patients with diabetes mellitus. New Engl J Med, 341, 1906-1912.
15. Kashiwagi, A., Asahina, T., Nishio, Y., Ikebuchi, M., Tanaka, Y., Kikkawa, R. and Shigeta, Y. (1996): Glycation, oxidative stress and scavenger activity: glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes, 45 (suppl. 3), S84-S86.
16. Katz, S., Klein, B., Elian, I., Fishman, P. and Djaldetti, M. (1983): Phagocytotic activity of monocytes from diabetic patients. Diabetes Care, 83, 479-482.
17. Kim, H.B., Chew, B.P., Wong, T.S., Park, J.S., Weng, B.B., Byrne, K.M., Hayek, M.G. and Reinhardt, G.A. (2000): Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol, 74, 315-327.
18. Li, N. and Karin, M. (1999): Is NF-kappaB the sensor of oxidative stress? FASEB J, 13, 1137-1143.
19. Miranda, M., Muriach, M., Johnsen, S., Bosch-Morell, F., Araiz, J., Romá, J. and Romero, F.J. (2004): Oxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidants. Arch Soc Esp Oftalmol, 79, 289-294.
20. Miranda, M., Muriach, M., Romá, J., Bosch-Morell, F., Genovés, J.M., Barcía, J., Araiz, J., Díaz-Llopis, M. and Romero, F.J. (2006): Oxidative stress in a model of experimental diabetic retinopathy, II. Peroxynitrite scavengers utility. Arch Soc Esp Oftalmol, 80, 27-32.
21. Muriach, M., Bosch-Morell, F., Alexander, G., Blomhoff, R., Barcia, J., Arnal, E., Almansa, I., Romero, F.J. and Miranda, M. (2006): Lutein effect on retina and hippocampus of diabetic mice. Free Radical Biol Med, 41, 979-984.
22. Nabi, A.H., Islam, L.M., Rahman, M.M. and Biswas, K.B. (2005): Polymorphonuclear neutrophil dysfunctions in streptozotocin-induced type 1 diabetic rats. J Biochem Mol Biol, 38, 661-667.
23. Packer, L., Kraemer, K. and Rimbach, G. (2001): Molecular aspects of lipoic acid in the prevention of diabetic complications. Nutrition, 17, 888-895.
24. Pahl, H.L. (1999): Activators and target genes of rel/NF-kappB transcription factors. Oncogene, 18, 6853-6866.
25. Pereira, M.A., Sannomiya, P. and Leme, J.G. (1987): Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma. Diabetes, 36, 1307-1314.
26. Reed, D.J., Babson, J.R., Beatty, P.W., Brodie, A.E., Ellis, W.W. and Potter, D.W. (1980): High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related disulfides. Anal Biochem, 106, 55-62.
27. Romero, M.J., Bosch-Morell, F., Romero, B., Rodrigo, J.M., Serra, M.A. and Romero, F.J. (1998): Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biol Med, 25, 993-997.
28. Rossi, D. and Zlotnik, A. (2000): The biology of chemokines and their receptors. Ann Rev Immunol, 18, 217-242.
29. Sawant, J.M. (1993): Biochemical changes in polymorphonuclear leukocytes in diabetic patients. Postgrad Med, 39, 183-186.
30. Schreck, R., Albertmann, K. and Bauerle, P.A. (1992): Nuclear factor kappa B: an oxidative stress-responses transcription factor of eukaryotic cells. Free Rad Res Commun, 17, 221-237.
31. Shah, B.R. and Hux, J.E. (2003): Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care, 26, 512-513.
32. Siebenlist, Q., Franzoso, G. and Brown, K. (1994): Structure, regulation and function of NFκB. Annu Rev Cell Biol, 10, 405-455.
33. VonKanel, R., Mills, P.J. and Dimsdale, J.E. (2001): Short-term hyperglycemia induces lymphopenia and lymphocytes subset redistribution. Life Sci, 69, 255-262.